Adverse Event reporting information can be found in footer
Request a Meeting
14% of IBD patients
exposed to steroids
experienced steroid excess
It was found that the
percentage of IBD patients
experiencing steroid excess
was higher in the local audit
than the national audit average
*According to ECCO guidelines, steroid excess is defined as >2 steroid courses within the preceding 12 months or disease flare on steroid withdrawal or within 3 months of stopping steroids2,9 †49% of patients diagnosed with UC. ‡52% of patients diagnosed with UC. Numbers are rounded to the nearest whole number.
CORTIMENT® maintains the efficacy of corticosteroids while minimising systemic side effects7
Long-term systemic steroid use is associated with a wide range of side effects
Induces depression and psychosis
⬆︎Hepatic glycogen deposition
⬆︎Peripheral insulin resistance
⬆︎Gluconeogenesis
⬆︎Free fatty acid production
Overall diabetogenic effect
Promotes visceral obesity
⬇︎Bone formation
⬇︎Bone mass and osteoporosis
Protein catabolism/collagen breakdown
Skin thinning
Muscular atrophy
⬇︎LH, FSH release
⬇︎Thyroid stimulating hormone release
⬇︎Growth hormone secretion
Glaucoma
Peptic ulcerations
Salt and water retention
Hypertension
⬇︎Linear growth
Anti-inflammatory action
Immunosuppression
CNS = Central nervous system;
LH = Lutenising hormone;
FSH = Follicle-stimulating hormone.
Adapted from Steward P, et al. Williams Textbook of Endocrinology.2011:479-544.
Job Code: UK-COR-2200001 - Date of preparation: January 2022